Portal Lenfadenopati ve Kolestatik Hepatitle Seyreden Epstein Barr Virüs Enfeksiyonu

Year 2016, Volume: 69 Issue: 2, 121 - 123, 20.10.2016

Elif Börekçi , Adem Kara , Çiğdem Kader , Tuğba Özdemir Tekin Yıldırım , Mehmet Çelikbilek

https://izlik.org/JA54PG33LH

Abstract

Epstein-Barr virus (EBV) is a B lymphotropic human herpes virus and have a widespread distribution in the world. It causes infectious mononucleosis (EM) which is known as the kissing disease because of transmission through saliva. EBV is a rare cause of acute hepatitis, cholestatic hepatitis in the course of the EBV infection is much more rare. In this paper, we report a case with cholestatic hepatitis and portal lymphadenopathy due to EBV infection.

Keywords

Epstein-Barr virüs , kolestatik hepatit , portal lenfadenopati

Ethical Statement

-

Supporting Institution

-

Thanks

-

Portal Lenfadenopati ve Kolestatik Hepatitle Seyreden Epstein Barr Virüs Enfeksiyonu

https://izlik.org/JA54PG33LH

Abstract

Epstein-Barr virüsü (EBV) dünyada yaygın bir dağılım gösteren B lenfotropik insan herpes virüsüdür. Tükrük yoluyla bulaștığı için öpücük hastalığı olarak da bilinen enfeksiyöz mononükleoz (EM) tablosuna neden olur. EBV akut hepatitin nadir bir nedeni olup kolestatik hepatit ise EBV enfeksiyonu seyrinde çok daha nadir görülmektedir. Biz bu yazıda EBV enfeksiyonuna bağlı kolestatik hepatit ve portal lenfadenopati gelișen bir olguyu sunduk.

Ethical Statement

-

Supporting Institution

-

Thanks

-

References

• 1. Odumade OA, Hogquist KA, Balfour HH, Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clinical microbiology reviews. 2011;24:193-209.
• 2. Macsween KF, Crawford DH. Epstein- Barr virus-recent advances. The Lancet Infectious diseases. 2003;3:131-40.
• 3. Auwaerter PG. Infectious mononucleosis in middle age. Jama. 1999;281:454-459.
• 4. Vine LJ, Shepherd K, Hunter JG, et al. Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis. Alimentary pharmacology & therapeutics. 2012;36:16-21.
• 5. Barreales M, Pérez-Carreras M, Meizoso T, et al., editors. [Epstein-Barr virus infection and acute cholestatic hepatitis]. Anales de medicina interna (Madrid, Spain: 1984); 2006.
• 6. Hinedi TB, Koff RS. CASE REPORT: Cholestatic Hepatitis Induced by Epstein- Barr Virus Infection in an Adult. Digestive diseases and sciences. 2003;48:539-541.
• 7. Fidan I, Yüksel S, İmir T. Değişik yaş gruplarında Epstein-Barr virus antikorlarının araştırılması. İnfeksiyon Dergisi (Turkish Journal of Infection). 2005;19:453-456.
• 8. Jenson HB. Acute complications of Epstein-Barr virus infectious mononucleosis. Current opinion in pediatrics. 2000;12:263-268.
• 9. Johannsen EC, Schooley R, Kaye K. Epstein-Barr virus (infectious mononucleosis). Principles and Practice of Infectious Diseases 6th ed Philadelphia, PA: Churchill Livingstone. 2005.
• 10. Finkel M, Parker GW, Fanselau Ha. The Hepatıtıs Of Infectıous Mononucleosıs: Experıence Wıth 235 Cases. Military medicine. 1964;129:533-538.
• 11. Crum NF. Epstein Barr virus hepatitis: case series and review. Southern medical journal. 2006;99:544-547.
• 12. Schaade L, Meilicke R, Büttgen S, et al. [Manganese superoxide dismutaseinhibiting autoantibodies in cholestatic Epstein-Barr viral hepatitis]. Deutsche medizinische Wochenschrift (1946). 1998;123:1478-1482.
• 13. Vuković VR, Mijailović Ž, Borovčanin N.Epstein-Barr virus hepatitis associated with icterus: Case report. Medicinski časopis. 2010;44:14-18.
• 14. Chalupa P, Kaspar M, Holub M. Acute acalculous cholecystitis with pericholecystitis in a patient with Epstein-Barr Virus infectious mononucleosis. Medical Science Review. 2009;15:CS30-CS3.
• 15. Dikici N, Ural O. Epsteın-Barr Vırus'a Bağlı Akut Kolestatik Hepatit: İki Olgu. İnfeksiyon Dergisi (Turkish Journal of Infection). 2009;23:197-200.
• 16. Rafailidis PI, Mavros MN, Kapaskelis A, et al. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2010;49:151-157.